Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tenaya Therapeutics

Clinical trials sponsored by Tenaya Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Gene therapy breakthrough? first human test of TN-201 for heart muscle disease begins Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

Gene therapy breakthrough? first human test of TN-201 for heart muscle disease begins

Disease control Recruiting now

This study tests a new gene therapy called TN-201 in 30 adults with hypertrophic cardiomyopathy caused by a specific genetic mutation (MYBPC3). The therapy is given as a one-time IV infusion and aims to correct the underlying genetic defect. The main goals are to check safety and…

Phase 1/2 • Sponsor: Tenaya Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC